Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1
Brianna M. Brooks(National Center for Advancing Translational Sciences), Catherine Z. Chen(National Institutes of Health), Kirill Gorshkov(National Center for Advancing Translational Sciences), Charles D. Yeh(National Institutes of Health), Chengyu Liu(National Institutes of Health), Jeanette Beers(National Institutes of Health), Jizhong Zou(National Institutes of Health), Yu‐Shan Cheng(National Institutes of Health), Wei Zheng(Liaoning Cancer Hospital & Institute)
Cited by 2
Related Papers
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
Modulation of β-Amyloid Precursor Protein Processing by the Low Density Lipoprotein Receptor-related Protein (LRP)
|Journal of Biological Chemistry|2000|263
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
|Emerging Microbes & Infections|2014|242
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
|ACS Pharmacology & Translational Science|2020|225